Results 141 to 150 of about 8,214 (218)

Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study. [PDF]

Medicina (Kaunas)
Guijarro LG, de Castro-Martínez P, Chaparro M, Acero-Sanz J, de León D, Guerra I, Iborra M, Cabriada JL, Bujanda L, Alba C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Hernández-Breijo B, Alvarez-Mon M, Gisbert JP, Ortega MA, PREDICROHN Study Group from GETECCU.   +23 more
europepmc   +1 more source

Identifying key clinical and biochemical predictors of treatment outcomes in inflammatory bowel disease: a real-world evidence study. [PDF]

Sci Rep
Rodríguez JLG, Parrado CV, Cordero-Ramos J, Bouallou A, Armengol de la Hoz MÁ, Arias FA.   +5 more
europepmc   +1 more source

Clinical and genetic description of patients with chronic granulomatous disease in a pediatric hospital [PDF]

Biomedica
Berriozábal-Villarruel X, Godínez-Zamora GF, Baeza-Capetillo P, Pérez-Blanco U, Espinosa-Padilla SE, Aguirre-Hernández J, Blancas-Galicia L, Saucedo-Ramírez OJ.   +7 more
europepmc   +1 more source

[Monitoring Serum Levels of Infliximab and Anti-Infliximab Antibodies in Pediatric Patients with Inflammatory Bowel Disease: Experience in a High Complexity Pediatric Hospital in Buenos Aires, Argentina]. [PDF]

Acta Gastroenterol Latinoam
Micheletti E, Eichhorn C, Antoniska M, García F, Pérez L, Weyersberg C, Contreras M.   +6 more
europepmc   +1 more source

Allelic and haplotypic HLA analysis in patients with psoriatic arthritis: Low frequency of common alleles [PDF]

Biomedica
Calixto OJ, Meneses-Toro MA, Chacón PA, Acevedo-Godoy M, Robayo LC, Bello-Gualtero JM, Bautista-Molano W, Noguera V, Cortés J, Romero-Sánchez C.   +9 more
europepmc   +1 more source

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU. [PDF]

Gut
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M, EXIT Study group of GETECCU.   +58 more
europepmc   +1 more source

GETECCU: a comprehensive national strategy for excellence in inflammatory bowel disease. [PDF]

Ther Adv Gastroenterol
Zabana Y, Gutiérrez A, Barreiro-de Acosta M, Nos P, Gisbert JP, Domènech E, Gomollón F, Hinojosa Del Val J, Gassull MÀ.   +8 more
europepmc   +1 more source

Una historia para pensar [PDF]

, 2017
Vega Belenguer, Raquel
core  

Enfermedad de Crohn: Diagnóstico y tratamiento

Revista de Gastroenterología de México, 2013
J.K. Yamamoto-Furusho
doaj   +1 more source

Probiotic Microorganisms in Inflammatory Bowel Diseases: Live Biotherapeutics as Food. [PDF]

Foods
Santos EN, Magalhães-Guedes KT, Borges FEM, Ferreira DD, da Silva DF, Conceição PCG, Lima AKC, Cardoso LG, Umsza-Guez MA, Ramos CL.   +9 more
europepmc   +1 more source